Data / Form D filings / C2N JMK, Inc.
C2N JMK, Inc.: Form D filing
C2N JMK, Inc., a biotechnology company in St. Louis, MO, filed a Form D with the SEC in 2025. The latest, on August 6, 2025, reports $10 million sold of a $10 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4340 DUNCAN AVENUE, St. Louis, MO, 63110
- Phone
- (877) 226-3424
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2079558
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | New notice | $9,999,891 | $9,999,891 | 2 | May 12, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jinzhu Yu | Executive Officer, Director |
Every Form D from the week of Aug 4, 2025 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what C2N JMK, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.